Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

GPBearishCorporate Developmentsnews

High materiality8/10

GreenPower Faces Nasdaq Bid-Price Rule, Delisting Risk and Cure Window

Oct 16, 2026, 4:42 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Listing-deficiency notices historically pressure micro-cap and small-cap names; immediate liquidity concerns and potential delisting risk tend to weigh on price until cure progress is evident. Similar episodes show volatility around threshold levels and possible dilution discussions if the cure is not progressing.

AI summary

What happened, with direct paths to the underlying reporting

GreenPower disclosed Nasdaq notified it that its share price has been below $1 for 30 consecutive trading days, triggering listing-rule non-compliance. It has up to 180 days (potentially extended) to regain compliance by closing above $1 for 10 consecutive days. The outcome could drive near-term volatility and prompt strategic actions to cure the deficiency.

GP received Nasdaq notice for closing price below $1 for 30 straight trading days.
Company out of compliance with Nasdaq listing rules; cure possible within 180 days.
Regain compliance requires price above $1 for 10 consecutive days within 180 days.
Failure could trigger an additional 180-day extension if other standards are met.
GreenPower is a maker of electric medium/heavy-duty vehicles.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.